The potential of DAOs for funding and collaborative development in the life sciences
VitaDAO funds longevity research through a blockchain-based decentralized autonomous organization (DAO), showcasing the potential of collaborative, transparent and alternative systems while also highlighting the challenges of coordination, regulation, biases and skepticism in reshaping traditional r...
Gespeichert in:
Veröffentlicht in: | Nature biotechnology 2024-04, Vol.42 (4), p.555-562 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 562 |
---|---|
container_issue | 4 |
container_start_page | 555 |
container_title | Nature biotechnology |
container_volume | 42 |
creator | Fantaccini, Simone Grassi, Laura Rampoldi, Andrea |
description | VitaDAO funds longevity research through a blockchain-based decentralized autonomous organization (DAO), showcasing the potential of collaborative, transparent and alternative systems while also highlighting the challenges of coordination, regulation, biases and skepticism in reshaping traditional research financing methods. |
doi_str_mv | 10.1038/s41587-024-02189-0 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3031660340</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3031660340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-5439498930ed0247edfd7841e39bd71b9d45d38295bd4bd8088b55ab660777503</originalsourceid><addsrcrecordid>eNp9kEtLxDAUhYMojo7-ARcScOOmmjSPJsthfILgZlyHtrnVSicZk3bAf286Myq4cBESuN859-QgdEbJFSVMXUdOhSoykvN0qNIZ2UNHVHCZUanlfnqTcUyFnKDjGN8JIZJLeYgmTAkpdJEfocXiDfDK9-D6tuywb_DN7DnixgfcDM627hWXzuLad11Z-VD27RqwhTV0frVMItw63CeLrm0Ax7oFV0M8QQdN2UU43d1T9HJ3u5g_ZE_P94_z2VNWs1z2meBMc600I2DTJwqwjS0Up8B0ZQtaacuFZSrXorK8soooVQlRVlKSoigEYVN0ufVdBf8xQOzNso01pKgO_BANI4wmmPERvfiDvvshuJRupLTMdb4xzLdUHXyMARqzCu2yDJ-GEjN2bradmxTXbDo3o-h8Zz1US7A_ku-SE8C2QEwj9wrhd_c_tl88r4qL</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3039629250</pqid></control><display><type>article</type><title>The potential of DAOs for funding and collaborative development in the life sciences</title><source>SpringerLink Journals</source><source>Nature Journals Online</source><creator>Fantaccini, Simone ; Grassi, Laura ; Rampoldi, Andrea</creator><creatorcontrib>Fantaccini, Simone ; Grassi, Laura ; Rampoldi, Andrea</creatorcontrib><description>VitaDAO funds longevity research through a blockchain-based decentralized autonomous organization (DAO), showcasing the potential of collaborative, transparent and alternative systems while also highlighting the challenges of coordination, regulation, biases and skepticism in reshaping traditional research financing methods.</description><identifier>ISSN: 1087-0156</identifier><identifier>ISSN: 1546-1696</identifier><identifier>EISSN: 1546-1696</identifier><identifier>DOI: 10.1038/s41587-024-02189-0</identifier><identifier>PMID: 38565972</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>706/703/253 ; 706/703/66 ; Agriculture ; Bioinformatics ; Biomedical and Life Sciences ; Biomedical Engineering/Biotechnology ; Biomedicine ; Biotechnology ; Blockchain ; Collaboration ; Comment ; Cryptography ; Decision making ; Digital currencies ; Funding ; Intellectual property ; Life Sciences ; Pharmaceutical industry ; Proposals ; Venture capital ; Voting rights ; Working groups</subject><ispartof>Nature biotechnology, 2024-04, Vol.42 (4), p.555-562</ispartof><rights>Springer Nature America, Inc. 2024</rights><rights>Springer Nature America, Inc. 2024.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-5439498930ed0247edfd7841e39bd71b9d45d38295bd4bd8088b55ab660777503</cites><orcidid>0000-0002-0720-7034</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41587-024-02189-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41587-024-02189-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38565972$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fantaccini, Simone</creatorcontrib><creatorcontrib>Grassi, Laura</creatorcontrib><creatorcontrib>Rampoldi, Andrea</creatorcontrib><title>The potential of DAOs for funding and collaborative development in the life sciences</title><title>Nature biotechnology</title><addtitle>Nat Biotechnol</addtitle><addtitle>Nat Biotechnol</addtitle><description>VitaDAO funds longevity research through a blockchain-based decentralized autonomous organization (DAO), showcasing the potential of collaborative, transparent and alternative systems while also highlighting the challenges of coordination, regulation, biases and skepticism in reshaping traditional research financing methods.</description><subject>706/703/253</subject><subject>706/703/66</subject><subject>Agriculture</subject><subject>Bioinformatics</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedical Engineering/Biotechnology</subject><subject>Biomedicine</subject><subject>Biotechnology</subject><subject>Blockchain</subject><subject>Collaboration</subject><subject>Comment</subject><subject>Cryptography</subject><subject>Decision making</subject><subject>Digital currencies</subject><subject>Funding</subject><subject>Intellectual property</subject><subject>Life Sciences</subject><subject>Pharmaceutical industry</subject><subject>Proposals</subject><subject>Venture capital</subject><subject>Voting rights</subject><subject>Working groups</subject><issn>1087-0156</issn><issn>1546-1696</issn><issn>1546-1696</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLxDAUhYMojo7-ARcScOOmmjSPJsthfILgZlyHtrnVSicZk3bAf286Myq4cBESuN859-QgdEbJFSVMXUdOhSoykvN0qNIZ2UNHVHCZUanlfnqTcUyFnKDjGN8JIZJLeYgmTAkpdJEfocXiDfDK9-D6tuywb_DN7DnixgfcDM627hWXzuLad11Z-VD27RqwhTV0frVMItw63CeLrm0Ax7oFV0M8QQdN2UU43d1T9HJ3u5g_ZE_P94_z2VNWs1z2meBMc600I2DTJwqwjS0Up8B0ZQtaacuFZSrXorK8soooVQlRVlKSoigEYVN0ufVdBf8xQOzNso01pKgO_BANI4wmmPERvfiDvvshuJRupLTMdb4xzLdUHXyMARqzCu2yDJ-GEjN2bradmxTXbDo3o-h8Zz1US7A_ku-SE8C2QEwj9wrhd_c_tl88r4qL</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Fantaccini, Simone</creator><creator>Grassi, Laura</creator><creator>Rampoldi, Andrea</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7QR</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0720-7034</orcidid></search><sort><creationdate>20240401</creationdate><title>The potential of DAOs for funding and collaborative development in the life sciences</title><author>Fantaccini, Simone ; Grassi, Laura ; Rampoldi, Andrea</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-5439498930ed0247edfd7841e39bd71b9d45d38295bd4bd8088b55ab660777503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>706/703/253</topic><topic>706/703/66</topic><topic>Agriculture</topic><topic>Bioinformatics</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedical Engineering/Biotechnology</topic><topic>Biomedicine</topic><topic>Biotechnology</topic><topic>Blockchain</topic><topic>Collaboration</topic><topic>Comment</topic><topic>Cryptography</topic><topic>Decision making</topic><topic>Digital currencies</topic><topic>Funding</topic><topic>Intellectual property</topic><topic>Life Sciences</topic><topic>Pharmaceutical industry</topic><topic>Proposals</topic><topic>Venture capital</topic><topic>Voting rights</topic><topic>Working groups</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fantaccini, Simone</creatorcontrib><creatorcontrib>Grassi, Laura</creatorcontrib><creatorcontrib>Rampoldi, Andrea</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fantaccini, Simone</au><au>Grassi, Laura</au><au>Rampoldi, Andrea</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The potential of DAOs for funding and collaborative development in the life sciences</atitle><jtitle>Nature biotechnology</jtitle><stitle>Nat Biotechnol</stitle><addtitle>Nat Biotechnol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>42</volume><issue>4</issue><spage>555</spage><epage>562</epage><pages>555-562</pages><issn>1087-0156</issn><issn>1546-1696</issn><eissn>1546-1696</eissn><abstract>VitaDAO funds longevity research through a blockchain-based decentralized autonomous organization (DAO), showcasing the potential of collaborative, transparent and alternative systems while also highlighting the challenges of coordination, regulation, biases and skepticism in reshaping traditional research financing methods.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>38565972</pmid><doi>10.1038/s41587-024-02189-0</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-0720-7034</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1087-0156 |
ispartof | Nature biotechnology, 2024-04, Vol.42 (4), p.555-562 |
issn | 1087-0156 1546-1696 1546-1696 |
language | eng |
recordid | cdi_proquest_miscellaneous_3031660340 |
source | SpringerLink Journals; Nature Journals Online |
subjects | 706/703/253 706/703/66 Agriculture Bioinformatics Biomedical and Life Sciences Biomedical Engineering/Biotechnology Biomedicine Biotechnology Blockchain Collaboration Comment Cryptography Decision making Digital currencies Funding Intellectual property Life Sciences Pharmaceutical industry Proposals Venture capital Voting rights Working groups |
title | The potential of DAOs for funding and collaborative development in the life sciences |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T15%3A23%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20potential%20of%20DAOs%20for%20funding%20and%20collaborative%20development%20in%20the%20life%20sciences&rft.jtitle=Nature%20biotechnology&rft.au=Fantaccini,%20Simone&rft.date=2024-04-01&rft.volume=42&rft.issue=4&rft.spage=555&rft.epage=562&rft.pages=555-562&rft.issn=1087-0156&rft.eissn=1546-1696&rft_id=info:doi/10.1038/s41587-024-02189-0&rft_dat=%3Cproquest_cross%3E3031660340%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3039629250&rft_id=info:pmid/38565972&rfr_iscdi=true |